The ‘Four Cs’ Could Make You Big Bucks
|
More than a year ago, I recommended a basket of unknown and poorly covered biotech stocks I called the “four Cs”: Cepheid (NASDAQ: CPHD), Cerus Corporation (NASDAQ: CERS), Compugen Ltd. (NASDAQ: CGEN) and Curis, Inc. (NASDAQ: CRIS). Well, they all have risen dramatically, outperforming the general market. Cepheid tripled from its lows, Curis did the same, Cerus rose almost 400%, and Compugen did even better. Does that mean these biotech stocks have had their run? I don’t think so. What I like about these four stocks is that they have the potential to trade against a sluggish or declining market, which is a good thing since I believe we are in a double-dip recession and corporate profits in 2011 are going to greatly disappoint Wall Street. |
12 Little-Known Stocks That Will Lead the Mobile Internet Revolution |
Comments are currently unavailable. Please check back soon.